Zimmer Biomet Reports Strong Q2 2026 Results and Raises Full-Year Financial Guidance

Zimmer Biomet Holdings, Inc. reported strong second-quarter 2026 financial results, with net sales increasing 4.8% to $2.177 billion. The company also raised its full-year 2026 revenue and adjusted EPS guidance, citing solid performance and progress on key growth drivers.